Please sign in to follow a disease.
JW Pharmaceutical
Clinical trials sponsored by JW Pharmaceutical, explained in plain language.
A South Korean pharmaceutical company developing and marketing a range of medicines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo pill aims to tackle cholesterol in metabolic syndrome patients Results expected Dec 2026 (estimated)
- New skin cream tested on healthy people – no cure expected Results expected Dec 2026 (estimated)
- New combo pill showdown: which diabetes cocktail wins? Results expected Mar 2027 (estimated)